SEATTLE, WA, April 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Segra International Corp., a pioneer in micropropagation, also known as plant tissue culture, which is designed to help cultivators increase their yields, reduce harmful pathogens, and ultimately help scale production to meet growing medical and adult-use demand worldwide. The company plans to go public later in 2018.
Click here to receive Segra International updates prior to the company going public.
How Most Cannabis is Grown
You might think of seeds as the natural starting point for growing plants, but growing a plant from a seed takes a long time and each resulting plant is different.
Large-scale commercial cannabis cultivators prefer to use clones, or genetically identical plantlets, derived from mother plant cuttings or other methods. By cutting a healthy lower branch, placing it immediately into water, and transporting the clone into soil, these cultivators can grow genetically identical plants. The clones have a much shorter growing window than plants derived from seeds, while each plant has identical cannabinoid and terpene ratios.
The problem is that this approach is labor intensive and requires a lot of physical space to maintain mother plants. This space for mother plants and cloning could otherwise be used for production and generate revenue if not required for nursery operations. In addition, mother plants have a finite lifespan and are more susceptible to pathogens as a result of their long residence times. Any clones derived from a pathogen-carrying mother plant will have the same infections and carry those into the vegetative and flowering stages of production. All of this means that the current process is not efficient, safe, or scalable and could lead to complete crop (and strain) loss in the event of an uncontrollable pathogen outbreak - a cultivator’s worst nightmare.
Why Micropropagation?
Many traditional agricultural crops have faced these same issues, but they have managed to effectively scale using a tissue culture technique known as micropropagation.
Micropropagation is a method of plant propagation using extremely small pieces of plant tissue taken from a carefully chosen and prepared mother plant, and rapidly growing these under sterile laboratory conditions to produce new plants.
Most plantlets produced this way are sold at the rooting stage when the plantlet is ready to be acclimated the final growing environment. Commercial cannabis cultivators can purchase these plantlets and acclimate them to their unique growing environment before moving them into the main greenhouse. This process takes very little time compared to the time it takes to grow a plant from a seed or clone a plant from cuttings from a mother plant.
Click here to receive Segra International updates prior to the company going public.
Gaining Traction Among LPs
Many licensed producers are embracing tissue culture techniques and micropropagation as a way to dramatically lower their costs, reduce the risk of pathogens, and ensure the best products for patients and consumers. In fact, LPs can effectively increase their productive square footage by five to 20 percent by eliminating the space that was used for mothering plants. They can also avoid pathogens without the use of pesticides, creating cleaner and safer products.
Segra International’s recent partnership with The Hydropothecary Corporation (TSX-V: THCX) is a perfect example of these benefits. Under the terms of the deal, Segra will provide its expertise and unique tissue culture techniques to help the licensed producer scale up its operations to meet market demand in Canada’s upcoming recreational market this summer. The partnership is expected to rapidly scale into millions of plantlets per year.
“Working with Segra will allow us to meet one of the biggest challenges as we meet the demand for cannabis products across Canada and beyond, balancing quality and quantity in our cannabis production,” said Hydropothecary CEO Sebastien St-Louis. “Thanks to Segra’s plant tissue culture technique, we will scale up our production process while maintaining the industry-leading quality standards that have made us so successful.”
Looking Ahead
Segra International Corp. is targeting a major pain point for licensed producers and is developing micropropagation labs to deliver tens of millions of plantlets to LPs across Canada. The company plans to go public later in 2018.
Segra’s world-class management team includes Director of Tissue Culture, Dr. Sma Zobayed, a leading specialist in plant tissue culture with two patents related to the subject and over 50 published scientific papers; Chief Marketing Officer, Ian Davidson, who founded Davidson Organics, one of the largest cultivators in California; and, Chief Operations Officer, Ryan Tiberti, who has developed, built, and operated several multi-million dollar cannabis firms in the U.S.
Click here to receive Segra International updates prior to the company going public.
Please follow the link to read the full article: http://www.cannabisfn.com/micropropagation-future-cannabis-cultivation/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/